Literature DB >> 11422926

Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy.

B Descamps-Latscha1, T Drüeke, V Witko-Sarsat.   

Abstract

Oxidative stress, which results from a rupture in the natural balance between pro- and antioxidant systems, is considered as a major factor in dialysis-associated morbidity and mortality. Emerging pharmacologic and dialytic antioxidant therapeutic and dialysis strategies should enable us to reduce the harmful consequences of oxidative stress in dialysis patients. Moreover, since there is increasing evidence of oxidative stress long before the initiation of maintenance dialysis, antioxidant therapeutic strategies should probably be developed very early in the course of renal failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422926     DOI: 10.1046/j.1525-139x.2001.00052.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  27 in total

1.  Impact of low-dose urokinase in peritoneal dialysis on serum oxidative stress, nitric oxide and endothelin in cerebral infarction complicated with uremia.

Authors:  Zhong-Sen Qu; Qing-De Zhang; Liang Li
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis.

Authors:  Jacek Zachwieja; Marcin Zaniew; Waldemar Bobkowski; Ewa Stefaniak; Alfred Warzywoda; Danuta Ostalska-Nowicka; Agnieszka Dobrowolska-Zachwieja; Maria Lewandowska-Stachowiak; Aldona Siwińska
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

3.  Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications.

Authors:  V Kolagal; S A Karanam; P K Dharmavarapu; R D'Souza; S Upadhya; V Kumar; V Kedage; M S Muttigi; J K Shetty; M Prakash
Journal:  Indian J Nephrol       Date:  2009-01

4.  Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies.

Authors:  Samar K M Khalil; H A Amer; Adel M El Behairy; Mohamad Warda
Journal:  J Adv Res       Date:  2016-02-23       Impact factor: 10.479

Review 5.  New Pharmacological Interventions in Bipolar Disorder.

Authors:  Mario F Juruena; Luke A Jelen; Allan H Young; Anthony J Cleare
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 6.  Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease.

Authors:  Chih-Chien Sung; Yu-Chuan Hsu; Chun-Chi Chen; Yuh-Feng Lin; Chia-Chao Wu
Journal:  Oxid Med Cell Longev       Date:  2013-08-24       Impact factor: 6.543

Review 7.  Resveratrol: why is it a promising therapy for chronic kidney disease patients?

Authors:  Juliana F Saldanha; Viviane de O Leal; Peter Stenvinkel; José Carlos Carraro-Eduardo; Denise Mafra
Journal:  Oxid Med Cell Longev       Date:  2013-12-29       Impact factor: 6.543

8.  Changes in antioxidant status associated with haemodialysis in chronic kidney disease.

Authors:  Adeyemi Ogunleye; Akinwumi A Akinbodewa; Oluseyi A Adejumo; Tosin T Oluwafemi; Damilola A Akinfaderin
Journal:  Ghana Med J       Date:  2018-03

Review 9.  NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys.

Authors:  Sunil Joshi; Ammon B Peck; Saeed R Khan
Journal:  Oxid Med Cell Longev       Date:  2013-06-06       Impact factor: 6.543

10.  Nitrotyrosine level was associated with mortality in patients with acute kidney injury.

Authors:  Jing Qian; Huaizhou You; Qiuyu Zhu; Shuai Ma; Ying Zhou; Ying Zheng; Junfeng Liu; Dingwei Kuang; Yong Gu; Chuanming Hao; Feng Ding
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.